{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:39:57Z","timestamp":1791257997353,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.3816\/clml.2011.n.019","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T15:21:13Z","timestamp":1352820073000},"page":"99-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["CD138 Expression Helps Distinguishing Waldenstr\u00f6m's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL)"],"prefix":"10.3816","volume":"11","author":[{"given":"Marie-Christine","family":"Kyrtsonis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Levidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Korkolopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Koulieris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Bartzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Maltezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos A.","family":"Pangalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kalpadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros P.","family":"Vassilakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Salpeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Tsaftaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Patsouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Panayiotidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana K.","family":"Tzenou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLML.2011.n.019_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0954-6820.1944.tb03955.x","article-title":"Incipient myelomatosis or \u201cessential\u201d hyperglobulinemia with fibrinopenia \u2013 a new syndrome","volume":"117","author":"Waldenstrom","year":"1944","journal-title":"Acta Med Scand"},{"key":"10.3816\/CLML.2011.n.019_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/1097-0142(195607\/08)9:4<792::AID-CNCR2820090429>3.0.CO;2-B","article-title":"Follicular lymphoma: a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases","volume":"9","author":"Hicks","year":"1956","journal-title":"Cancer"},{"key":"10.3816\/CLML.2011.n.019_bib3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.019_bib4","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House Virginia","volume":"84","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLML.2011.n.019_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3816\/CLM.2005.n.006","article-title":"Differential diagnosis Of Waldenstrom's macroglobulinemia and other B-cell disorders","volume":"5","author":"Pangalis","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.3816\/CLML.2011.n.019_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.pap.0000184176.65919.17","article-title":"Lymphoplasmacytic lymphoma\/Waldenstrom's macroglobulinemia. An evolving concept","volume":"12","author":"Lin","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"10.3816\/CLML.2011.n.019_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"key":"10.3816\/CLML.2011.n.019_bib8","series-title":"Who classification of tumours of haematipoetic and lymphoid tissues","first-page":"194","article-title":"Lymphoplasmacytic lymphoma","author":"Swerdlow","year":"2008"},{"key":"10.3816\/CLML.2011.n.019_bib9","series-title":"Clinical Methods: The history, Physical and Laboratory examinations","article-title":"Sensitivity, specificity and predictive valuey","author":"Simon","year":"1990"},{"key":"10.3816\/CLML.2011.n.019_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2141.1996.d01-1811.x","article-title":"A plasmocyte selective monoclonal antiboby (B-B4) recognizes syndecan-1","volume":"94","author":"Wijdenes","year":"1996","journal-title":"Br J Haematol"},{"key":"10.3816\/CLML.2011.n.019_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1091\/mbc.1.1.27","article-title":"B lymphocytes express and lose syndecan at specific stages of differentiation","volume":"1","author":"Sanderson","year":"1989","journal-title":"Cell Regulation"},{"key":"10.3816\/CLML.2011.n.019_bib12","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.148.12.3902","article-title":"Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by the integral membrane proteoglycan, syndecan","volume":"148","author":"Sanderson","year":"1992","journal-title":"Journal of Immunology"},{"key":"10.3816\/CLML.2011.n.019_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3270001","article-title":"Syndecans: multifunctional cell-surface co-receptors","volume":"327","author":"Carey","year":"1997","journal-title":"Biochemical Journal"},{"key":"10.3816\/CLML.2011.n.019_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2141.1999.01211.x","article-title":"Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas","volume":"104","author":"Sebesty\u00e9n","year":"1999","journal-title":"Br J Haematol"},{"key":"10.3816\/CLML.2011.n.019_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.0902-4441.2003.00205.x","article-title":"Serum syndecan-1, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and osteoprotegerin (OPG) in myeloma (MM) patients","volume":"72","author":"Kyrtsonis","year":"2004","journal-title":"European J Haematol"},{"issue":"suppl 2","key":"10.3816\/CLML.2011.n.019_bib16","first-page":"223","article-title":"Serum soluble syndecan-1 is increased in WM\/LPL and SMZL","volume":"92","author":"Kyrtsonis","year":"2007","journal-title":"Haematologica\/The Hematology Journal"},{"key":"10.3816\/CLML.2011.n.019_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1309\/4LCN-JMPG-5U71-UWQB","article-title":"Waldenstrom's macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors","volume":"116","author":"Owen","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLML.2011.n.019_bib18","first-page":"308","article-title":"Clinicopathologic features of lymphoplasmacytic lymphoma","volume":"39","author":"Liu","year":"2010","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.3816\/CLML.2011.n.019_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cyto.b.20463","article-title":"Mantle Cell Lymphoma with Flow Cytometric Evidence of Clonal Plasmacytic Differentiation: A Case Report","volume":"76B","author":"Naushad","year":"2009","journal-title":"Clinical Cytometry"},{"key":"10.3816\/CLML.2011.n.019_bib20","first-page":"1234","article-title":"The phenotype of normal, reactive and malignant plasma cells. Identification of \u201cmany and multiple myelomas\u201d and of new targets for myeloma therapy","volume":"91","author":"Bataille","year":"2006","journal-title":"Haematologica"},{"key":"10.3816\/CLML.2011.n.019_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2009.34","article-title":"Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstr\u00f6m's macroglobulinemia","volume":"22","author":"Morice","year":"2009","journal-title":"Modern Pathology"},{"key":"10.3816\/CLML.2011.n.019_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/sonc.2003.50074","article-title":"Immunophenotypic analysis of Waldenstrom's macroglobulinemia","volume":"30","author":"San Miguel","year":"2003","journal-title":"Semin Oncol"},{"key":"10.3816\/CLML.2011.n.019_bib23","unstructured":"deTute R. Development of specific phenotyping. Proceeding of the 6th International Workshop on Waldenstrom's macroglobulinemia. Venice, Italy; October 10, 2010."},{"key":"10.3816\/CLML.2011.n.019_bib24","unstructured":"Morice WG. Novel immunophenotypic features of Waldenstrom's macroglobulinemia. Proceeding of the 6th International Workshop on Waldenstrom's macroglobulinemia. Venice, Italy; October 10, 2010."},{"key":"10.3816\/CLML.2011.n.019_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00277-001-0385-8","article-title":"Waldenstrom's macroglobulinemia: Clinical course and prognostic factors in 60 patients. Experience From a Single Haematology Unit","volume":"80","author":"Kyrtsonis","year":"2001","journal-title":"Ann Haematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265011701409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265011701409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:23:13Z","timestamp":1761870193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265011701409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S2152265011701409"],"URL":"https:\/\/doi.org\/10.3816\/clml.2011.n.019","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD138 Expression Helps Distinguishing Waldenstr\u00f6m's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL)","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLML.2011.n.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}